首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1419142

机器人辅助手术系统市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品类型、应用、最终用户和地理位置

Robotic Assisted Surgery Systems Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Geography

出版日期: 2023年11月30日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

机器人辅助手术系统市场预计将从2022年的78.31亿美元成长到2030年的238.16亿美元；预计2022年至2030年CAGR为14.9%。

机器人辅助手术系统市场包括越来越多技术先进的手术平台，这些平台整合了机器人、影像和导航系统，以帮助外科医生以更高的精度和控制执行微创手术。这些系统旨在增强手术能力、改善患者治疗效果并最大限度地减少传统手术技术的侵入性。机器人辅助手术系统具有一系列优势，包括增强的灵活性、三维可视化和震颤过滤，使外科医生能够以更高的准确性和可操作性执行复杂的手术。这些系统通常使外科医生能够进入难以到达的解剖区域，从而减少创伤并加快患者康復时间。此外，众所周知，机器人技术在手术中的整合可以最大限度地降低併发症的风险，降低输血的需求，并最终有助于改善术后结果。

慢性病盛行率的不断上升推动了药物发现服务市场的成长。

在整个预测期间，预计越来越多的利用机器人辅助操作的研究将推动市场扩张。例如，2022 年 9 月，名古屋市立大学 (NCU) 医学科学研究生院团队进行了一项研究，比较机器人辅助萤光镜引导和超音波引导肾入路进行经皮肾镜取石术。研究的结果支持了革命性机器人设备的安全性和易用性，这可能会减轻外科医生的培训负担，并使更多的医院能够执行 PCNL 手术。这种方法使用人工智慧驱动的机器人技术，可能为类似介入手术程序的自动化打开大门，这可能会加快流程并可能降低併发症的风险。

此外，由于慢性病病例的增加以及微创手术相对开放性手术和成功率的优势而日益普及，机器人辅助手术系统的市场正在扩大。例如，根据《印度教徒报》2022 年 8 月发布的消息称，海得拉巴的阿波罗健康城已在印度完成了 500 多例机器人辅助妇科手术。因此，该国越来越多地使用微创手术（比开放手术痛苦更少），推动了市场的成长。

2022年11月，美敦力公司全资子公司India Medtronic Private Limited和德里的Venkateshwar医院也报告了印度北部首例使用Hugo机器人辅助手术（RAS）系统完成的泌尿外科治疗。

机器人辅助手术系统市场根据流程、类型、分子类型、治疗领域和最终用户进行划分。根据流程，机器人辅助手术系统市场分为目标选择和验证、先导化合物识别等。按类型划分，机器人辅助手术系统市场分为生物服务、医学服务化学药物代谢和药物动力学。从分子类型来看，机器人辅助手术系统市场分为生物製剂和小分子。根据治疗领域，机器人辅助手术系统市场分为心血管疾病、肿瘤、神经学、糖尿病、呼吸系统疾病等。此外，最终用户部分分为製药和生技公司、学术机构和其他。

机器人辅助手术系统市场根据产品类型、应用和最终用户进行划分。根据产品类型，机器人辅助手术系统市场分为系统、消耗品和配件以及软体和服务。依应用划分，机器人辅助手术系统市场分为妇科手术、心血管、神经外科、骨科手术、腹腔镜、泌尿外科和其他应用。此外，最终使用者部分分为医院、门诊手术中心和其他最终使用者。根据地理位置，机器人辅助手术系统市场分为北美（美国、加拿大和墨西哥）、欧洲（英国、德国、法国、义大利、西班牙和欧洲其他地区）、亚太地区（中国、日本、印度、韩国、澳洲和亚太地区其他地区）、中东和非洲（阿联酋、沙乌地阿拉伯、南非以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷），以及南美洲和中美洲的其他地区）。

根据地理位置，机器人辅助手术系统市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美是机器人辅助手术系统市场成长最重要的贡献者。自动化手术器械的使用不断增加以及美国下一代医疗系统设施的发展推动了该区域市场。此外，预计与患者人数相比，美国外科医生和医疗专业人员的缺乏将推动机器人辅助手术系统的区域市场。此外，美国糖尿病、癌症和心血管疾病等慢性病盛行率的增加也推动了该地区对机器人辅助手术系统的需求。机器人辅助手术系统市场的主要参与者大多专注于技术开发并推出新的机器人器材以保持领先地位。此外，全球对自动化手术设备不断增长的需求可能会促进新公司进入市场。此外，预计由于重要产业参与者透过併购、收购和合作伙伴关係取得策略性工业市场进步，竞争对手将变得更具竞争力。

疾病管制与预防中心 (CDC) 和食品药物管理局 (FDA) 是在准备药物发现服务市场报告时提到的几个关键的主要和次要来源。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 11 章：Covid-19 前后的影响

第 12 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第13章：竞争格局

关键参与者的热图分析
公司定位与专注

第 14 章：机器人辅助手术系统市场 - 主要公司概况

Intuitive Surgical Inc.

注意 - 将为以下公司列表提供类似信息

史赛克公司
强生公司
SRI国际公司
安科瑞公司
雷尼绍公司
美敦力公司
史密斯和侄子有限公司
大脑实验室
格洛布斯医疗

第 15 章：附录

词彙表
关于 Insight Partners
市场情报云

简介目录

Product Code: TIPRE00004753

The robotic-assisted surgery systems market is expected to grow from US$ 7.831 billion in 2022 to US$ 23.816 billion by 2030; it is anticipated to record a CAGR of 14.9% from 2022 to 2030.

The robotic-assisted surgery systems market encompasses a growing array of technologically advanced surgical platforms that integrate robotics, imaging, and navigation systems to assist surgeons in performing minimally invasive procedures with increased precision and control. These systems are designed to enhance surgical capabilities, improve patient outcomes, and minimize the invasiveness of traditional surgical techniques. Robotic-assisted surgery systems offer a range of benefits, including enhanced dexterity, three-dimensional visualization, and tremor filtration, allowing surgeons to perform complex procedures with greater accuracy and maneuverability. These systems often enable surgeons to access difficult-to-reach anatomical areas, leading to reduced trauma and faster patient recovery times. Additionally, the integration of robotic technology in surgery is known to minimize the risk of complications, lower the need for blood transfusions, and ultimately contribute to improved post-operative outcomes.

The increasing prevalence of chronic diseases drives the growth of the drug discovery services market.

Throughout the projected period, increasing research studies utilizing robotic-assisted operations are anticipated to fuel market expansion. For instance, in September 2022, a study comparing robotic-assisted fluoroscopic-guided and ultrasound-guided renal access for percutaneous nephrolithotomy was carried out by the Nagoya City University (NCU) Graduate School of Medical Sciences team. The study's findings supported the revolutionary robotic device's safety and ease of use, which may lessen the training burden on surgeons and enable more hospitals to perform PCNL procedures. This method, which uses robotics driven by artificial intelligence, may open the door to the automation of comparable interventional surgery procedures, which might speed up the process and possibly lower the risk of complications.

Additionally, the market for robotically assisted surgical systems is expanding as a result of the rise in chronic disease cases and the growing popularity of minimally invasive surgeries due to their advantages over open surgery and success rate. For example, according to news released by The Hindu in August 2022, Apollo Health City in Hyderabad has completed more than 500 robotically assisted gynecological procedures in India. As a result, the country's growing use of MIS procedures-which are less painful than open surgery-is fueling the market's rise.

In November 2022, the first urological treatment in north India to be completed with the Hugo robotic-assisted surgery (RAS) system was also reported by India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, and Venkateshwar Hospital in Delhi.

The robotic-assisted surgery systems market is divided on the basis of process, type, molecule type, therapeutic area, and end user. Based on the process, the robotic assisted surgery systems market is segmented into target selection and validation, hit to lead identification, and others - assay development and screening, etc. By type, the robotic assisted surgery systems market is segmented into biology services, medicinal chemistry drug metabolism, and pharmacokinetics. In terms of molecule type, the robotic assisted surgery systems market is classified as biologics and small molecules. On the basis of therapeutic areas, the robotic assisted surgery systems market is differentiated into cardiovascular diseases, oncology, neurology, diabetes, respiratory diseases, and others. Furthermore, the end-user segment is classified into Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others.

The robotic assisted surgery systems market is divided on the basis of product type, application, and end user. Based on the product type, the robotic assisted surgery systems market is segmented into systems, consumables and accessories, and software and services. By application, the robotic assisted surgery systems market is segmented into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, and other applications. Furthermore, the end-user segment is classified into hospitals, ambulatory surgery centers, and other end-users. Based on geography, the robotic assisted surgery systems market is divided into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Based on geography, the robotic assisted surgery systems market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of the robotic assisted surgery systems market. The regional market is being driven by the growing use of automated surgical instruments and the growth of next-generation healthcare system facilities in the US. Furthermore, it is projected that the lack of surgeons and medical professionals in the US compared to the patient population will push the regional market for robot-assisted surgical systems. Furthermore, the need for robot-assisted surgical systems in this region is being driven by the increased prevalence of chronic diseases like diabetes, cancer, and cardiovascular disease in the US. Major players in the market for robot-assisted surgical systems mostly focus on technology development and launch new robotic instruments to keep their leading positions. Furthermore, the growing need for automated surgical equipment across the globe would likely promote the entry of new companies into the market. Furthermore, it is anticipated that rivals would become more competitive as a result of strategic industrial market advancements made by significant industry players through mergers, acquisitions, and cooperative partnerships.

Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are a few key primary and secondary sources referred to while preparing the report on the drug discovery services market.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Robotic Assisted Surgery Systems Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Robotic Assisted Surgery Systems Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Robotic Assisted Surgery Systems Market - Global Market Analysis

6.1 Robotic Assisted Surgery Systems - Global Market Overview
6.2 Robotic Assisted Surgery Systems - Global Market and Forecast to 2030

7. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By Product Type, 2020-2030

7.1 Overview
7.2 System
7.3 Consumable and Accessories
7.4 Software and Services

8. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Gynecological Surgery
8.3 Cardiovascular
8.4 Neurosurgery
8.5 Orthopedic Surgery
8.6 Laparoscopy
8.7 Urology
8.8 Other Applications

9. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgery Centers
9.4 Other End Users

10. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Robotic Assisted Surgery Systems Market Overview
- 10.1.2 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts to 2030
- 10.1.3 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Product Type
- 10.1.4 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Robotic Assisted Surgery Systems Market
    - 10.1.6.1.1 United States Robotic Assisted Surgery Systems Market, by Product Type
    - 10.1.6.1.2 United States Robotic Assisted Surgery Systems Market, by Application
    - 10.1.6.1.3 United States Robotic Assisted Surgery Systems Market, by End User
  - 10.1.6.2 Canada Robotic Assisted Surgery Systems Market
    - 10.1.6.2.1 Canada Robotic Assisted Surgery Systems Market, by Product Type
    - 10.1.6.2.2 Canada Robotic Assisted Surgery Systems Market, by Application
    - 10.1.6.2.3 Canada Robotic Assisted Surgery Systems Market, by End User
  - 10.1.6.3 Mexico Robotic Assisted Surgery Systems Market
    - 10.1.6.3.1 Mexico Robotic Assisted Surgery Systems Market, by Product Type
    - 10.1.6.3.2 Mexico Robotic Assisted Surgery Systems Market, by Application
    - 10.1.6.3.3 Mexico Robotic Assisted Surgery Systems Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Robotic Assisted Surgery Systems Market - Key Company Profiles

14.1 Intuitive Surgical Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies